FDA Inspection 1024415 — Harborview Medical Center

Harborview Medical Center — FEI 3000281640

The FDA completed an inspection of Harborview Medical Center on August 14, 2017 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 14, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Seattle, WA (United States)